UpdatesPress Release

Shaily announced its ShailyPen Neo™ device received key regulatory approvals for a generic Semaglutide injection.

Shaily Engineering Plastics Limited logo
Shaily Engineering Plastics LimitedSHAILY · Filed with the exchange

The product, launched in Canada and available in India, highlights Shaily's pivotal role in advanced drug delivery systems and expands its market footprint.

Read the original filing(PDF)

No comments yet. Be the first.

More from Shaily Engineering Plastics Limited

All announcements